Form 4 Tracker
Martine A Rothblatt

Director; Director, Chairperson & CEO · 120 filings · Latest: Aug 13, 2026

BETA Technologies, Inc.
UNITED THERAPEUTICS Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
UTHR
Martine A RothblattDirector, Chairperson & CEOJul 2, 2026
Option Exercise
$135.429,500$1.3M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOJul 1, 2026
Sale
$543.669,500$5.2M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOJul 1, 2026
Option Exercise
$135.429,500$1.3M50,013
UTHR
MARTINE ROTHBLATTJul 1, 2026
Proposed Sale
$541.83209,000$113.2M
UTHR
Martine A RothblattDirector, Chairperson & CEOJun 30, 2026
Sale
$541.009,500$5.1M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOJun 30, 2026
Option Exercise
$135.429,500$1.3M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOJun 29, 2026
Sale
$545.809,500$5.2M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOJun 29, 2026
Option Exercise
$135.429,500$1.3M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOJun 26, 2026
Sale
$543.979,500$5.2M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOJun 26, 2026
Option Exercise
$135.429,500$1.3M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOJun 25, 2026
Sale
$550.409,500$5.2M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOJun 25, 2026
Option Exercise
$135.429,500$1.3M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOJun 24, 2026
Sale
$548.699,500$5.2M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOJun 24, 2026
Option Exercise
$135.429,500$1.3M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOJun 23, 2026
Sale
$543.959,500$5.2M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOJun 23, 2026
Option Exercise
$135.429,500$1.3M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOJun 22, 2026
Sale
$537.749,500$5.1M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOJun 22, 2026
Option Exercise
$138.679,500$1.3M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOJun 18, 2026
Sale
$540.189,500$5.1M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOJun 18, 2026
Option Exercise
$146.039,500$1.4M50,013